×

Transretinal implant and method of manufacture

  • US 9,993,367 B2
  • Filed: 07/31/2006
  • Issued: 06/12/2018
  • Est. Priority Date: 03/21/2003
  • Status: Active Grant
First Claim
Patent Images

1. An implantable device to deliver drugs to an eye, the eye having a retina, a sclera, a fovea, and a vitreous cavity, the implantable device comprising:

  • a retinal implant that is configured to be implanted subretinally under the fovea for drug release, including a drug delivery device;

    a drug reservoir, configured to be on an external surface of the sclera; and

    at least one delivery conduit between the drug reservoir and the retinal implant, wherein the at least one delivery conduit is configured to be implanted passing transretinally through a reverse curve into the vitreous cavity of the eye, passing through the sclera at a pars plana, a point where there is no retina, and be attached to the drug reservoir while the drug reservoir is located on the sclera within a body, outside the eye, wherein the implantable device is configured to transfer the drugs from the drug reservoir while the drug reservoir is located on the sclera.

View all claims
  • 4 Assignments
Timeline View
Assignment View
    ×
    ×